Literature DB >> 7210703

Identification of the major biliary metabolite of (+)-catechin in the rat.

I C Shaw, L A Griffiths.   

Abstract

1. Following oral administration of [U-14C]-(+)-catechin to the rat, the major biliary metabolite was shown to be the glucuronide of 3'-O-methyl-(+) catechin by chromatography and mass spectrometry. 2. [methyl-14C]-O-Methyl-(+)-catechin was formed by incubation of (+)-catechin with S-adenosyl-L-[methyl-14C]methionine in vitro in both liver homogenates and in the presence of purified catechol-O-methyl transferase. 3. Alkaline micro-fusion techniques have been used to determine the position of the O-methyl substituent in the B-ring of the isolated O-methyl-(+)-catechin glucuronide.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7210703     DOI: 10.3109/00498258009033824

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  5 in total

1.  New metabolites of the naturally-occurring mutagen, quercetin, the pro-mutagen, rutin and of taxifolin.

Authors:  S Brown; L A Griffiths
Journal:  Experientia       Date:  1983-02-15

2.  Flavonoids and urate antioxidant interplay in plasma oxidative stress.

Authors:  P Filipe; V Lança; J N Silva; P Morlière; R Santus; A Fernandes
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

3.  Identification of the major urinary metabolites of (+)-catechin and 3-O-methyl-(+)-catechin in man.

Authors:  M Wermeille; E Turin; L A Griffiths
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

4.  3'-O-methyl-(+)-catechin glucuronide and 3'-O-methyl-(+)-catechin sulphate: new urinary metabolites of (+)-catechin in the rat and the marmoset.

Authors:  A M Hackett; I C Shaw; L A Griffiths
Journal:  Experientia       Date:  1982-05-15

5.  The disposition of 3-O-methyl-(+)-catechin in the rat and the marmoset following oral administration.

Authors:  A M Hackett; L A Griffiths
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.